期刊文献+

培美曲塞脂质体的制备及其对乳腺癌的作用观察 被引量:3

Preparation of liposomal pemetrexed and its effects on breast cancer
下载PDF
导出
摘要 目的·制备培美曲塞脂质体,观察其对乳腺癌细胞MCF-7及荷瘤裸鼠模型肿瘤的抑制作用。方法·采用薄膜分散法制作脂质体,CCK-8法检测其对MCF-7细胞的抑制作用;建立Balb/c裸鼠荷瘤模型,通过尾静脉给药以检测其抑瘤作用。结果·培美曲塞脂质体可抑制MCF-7细胞增殖,当培美曲塞浓度分别为0.20、0.40和10.00μg/m L时,实验组(培美曲塞脂质体)的细胞生存率显著小于对照组(等浓度梯度培美曲塞),P值分别为0.013、0.035和0.041。与空白组(等剂量PBS)比较,实验组(培美曲塞脂质体)和对照组(等剂量培美曲塞)Balb/c裸鼠肿瘤的体积和质量均显著减小;实验组肿瘤的体积和质量也均显著小于对照组(均P=0.000)。结论·相对于培美曲塞原料药物,脂质体能抑制MCF-7细胞的增殖,通过尾静脉给药能有效抑制肿瘤在Balb/c裸鼠体内的生长。 To prepare the liposomal pemetrexed and investigate its effects on MCF-7 breast cancer cells in vitro and nude mice bearing MCF-7 xenograft tumors. Methods · Liposomal pemetrexed was prepared by film dispersion method. Inhibition of MCF-7 breast cancer cell lines was evaluatedby CCK-8 method, and anti-tumor effects were investigated on Balb/c nude mice bearing MCF-7 xenograft tumors. Results · Liposomal pemetrexed inhibited the growth of MCF-7 cells. When the concentrations of pemetrexed were 0.20, 0.40 and 10.00 μg/mL, the cell viability in experiment group (liposomal pemetrexed) was significantly lower than that in control group (pemetrexed of same concentration gradient), with P values of 0.013, 0.035 and 0.041, respectively. Compared with blank group (same volume of PBS), the volumes and weights of tumors of nude mice in experiment group(liposomal pemetrexed) and control group (same volume of pemetrexed) were significantly lower, and the volume and weight of tumor in experiment group were also significantly lower than those in control group (P=0.000). Conclusion · Compared to bulk drug of pemetrexed, liposomal pemetrexed can inhibit the growth of MCF-7 breast cancer cells and the Balb/c nude mice bearing MCF-7 xenograft tumors.
作者 柏方 陈婷 刘艳 吴克瑾 陈青 陆云姝 葛梅馨 BAI Fang;CHEN Ting;LIU Yan;WU Ke-jin;CHEN Qing;LU Yun-shu;GE Mei-xin(Department of General Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;Department of Pharmacy, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;Department of Breast Surgery, Obstetrics and Gynaecology Hospital, Fudan University, Shanghai 200011, China)
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2017年第2期190-192,共3页 Journal of Shanghai Jiao tong University:Medical Science
基金 上海市卫生和计划生育委员会基金(20154Y0077) 上海高校选拔培养优秀青年教师科研专项基金(zzjdyx13087) 上海交通大学医学院附属新华医院基金(14YJ25)~~
关键词 培美曲塞 脂质体 乳腺癌 MCF-7细胞 BALB/C裸鼠 pemetrexed liposome breast neoplasm MCF-7 cell Balb/c nude mouse
  • 相关文献

参考文献1

二级参考文献8

  • 1Moulder S, Hortobagyi GN. Advances in the treatment of breast cancer [ J]. Clin Pharmacol Ther,2008,83 ( 1 ) :26-36.
  • 2Wang H, Vo T, Hajar A, et al. Multiple mechanisms underlying ac- quired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells[ J]. BMC Cancer,2014,14 ( 37 ) : 1471-2407.
  • 3Park SH, Cho EK, Bang SM, et al. Docetaxel plus cisplatin is effective for patients with metastatic breast cancer resistant to previous anthra- cycline treatment: a phase II clinical trial [ J ]. BMC Cancer, 2005,5 (21) : 1471-2407.
  • 4Oostendorp LJ, Stalmeier PF, Danders AR, et al. Efficacy and safety of palliative chemotherapy for patients with advanced breast cancer pre- treated with anthracyclines and taxanes:a systematic review [ J ]. Lan- cet Onco1,2011,12 ( 11 ) : 1053-1061.
  • 5Nabholtz JM, Reese DM, Lindsay MA, et al. Docetaxel in the treatment of breast cancer:an update on recent studies [ J ]. Semin 0ncol,2002, 29(3 suppl) :28-34.
  • 6Lin YC, Chang HK, Chen JS, et al. A phase II randomized study of two taxanes and cisplatin for metastatic breast cancer after anthracycline : a final analysis[J]. Jpn J Clin 0ncol,2007,37( 1 ) :23-29.
  • 7臧梦芳,张咏梅,智英辉,翟震,张敏,谷峰,付丽,只向成.乳腺癌对吡柔比星和表柔比星的药物敏感性及有效性的对比观察[J].中华医学杂志,2011,91(20):1388-1392. 被引量:15
  • 8查全斌,唐金海,季明华,吴建中,乔恩奇,何跃君.多西他赛对三阴性乳腺癌细胞株增殖影响及其机制的探讨[J].中华肿瘤防治杂志,2012,19(23):1761-1766. 被引量:3

共引文献14

同被引文献34

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部